explore -WSS

explore

author：Wikipedia 2025-10-01 17:05:44 - browse：6

Matts Take Column Illustration — Molly Ferguson for STAT

What do you say to a patient when the FDA rejects “their” experimental drug — one that they believe can alleviate at least some of their suffering?

That question arises in the aftermath of a dramatic moment at the Food and Drug Administration last week. Over the FDA’s protests, a small biotechnology company called BrainStorm Cell Therapeutics had insisted that the agency evaluate its experimental treatment for amyotrophic lateral sclerosis, or ALS, brand named NurOwn. ALS patients made fervent pleas for the medicine, a type of stem cell preparation, based on reports on social media and re-analyses of the data that they thought indicated it might be of some help to those with the fatal disease.

But the FDA methodically dismantled BrainStorm’s application. The medicine couldn’t work the way the company said it would, the agency insisted; the clinical trials didn’t show it was effective; and it was not clear BrainStorm could manufacture the medicine with sufficient quality. Worst of all, more patients died among those who received the drug than those who got placebo. The FDA’s panel of expert advisers voted 17 to 1 that the medicine was not safe and effective, with one person abstaining. The agency doesn’t have to follow the panel’s advice but probably will.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： What to expect as Trump is arraigned on his Jan 6. indictment

entertainment

focus

WSS

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Micronoma's microbiome cancer diagnostic approach under fire

Physician groups backed by private equity giant lobby on mergers

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

NIH launches clinical trials and new research office for long Covid

Ending health disparities requires full federal government, panel says

explore

explore

hotspot

Continuity nursing helped my family in our darkest PICU moments

National panel will explore requiring free Covid tests

Affirmative action in medical school literally saved lives

New safety details link Apellis eye drug to rare cases of blindness

Medicare details structure of new drug price negotiation program

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

United colonoscopy coverage change 'may cost lives,' doctors say

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Novavax promises a turnaround & Lilly roils the obesity market

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

focus

Amazon expands telehealth clinic nationwide

Physician groups backed by private equity giant lobby on mergers

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Sage hopes for a blockbuster in antidepressant now before FDA

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

entertainment

knowledge

focus

knowledge